Raeliva review

A wider catalogue still needs a defined purpose

OnlineSemaglutide.org has become Raeliva under the same operating company, according to its official rebrand explanation. The current site lists weight-care compounds, NAD+ and sermorelin. That expanded scope can simplify finding a service to investigate, but does not establish that multiple prescriptions belong in a preventive plan. ^{[1] [6] [12] [13]}

Begin with the decision the service would add to existing care. A symptom, an abnormal measurement and a general wish to age well are different starting points. The number of available products does not determine the appropriate response.

Compare the defined role in our health-service comparisons.

Match each equivalent to the actual payment

NAD+ and sermorelin each list $179 month to month and a $1,400 twelve-month upfront option, advertised as roughly $117 per month. Semaglutide and tirzepatide injections have separate monthly and prepaid terms; their six-month charges are $900 and $1,450 respectively. These are distinct purchases, not one price for a broad health program. ^{[7] [8] [12] [13]}

The NAD+ and sermorelin inclusion panels say required labs may cost extra. Confirm the selected preparation, usable supply and testing before estimating a complete commitment. A prepaid term is not evidence of how much medicine will arrive at once or a guarantee that an unused balance is refundable. ^{[12] [13]}

Separate the actual commitments in the full care-cost planner.

Understand the division of responsibility

Pacific Shores operates the website and intake front end, while CareValidate runs the clinical and billing experience. The site identifies an independent medical practice and a network of licensed pharmacies. The actual responsible practice and dispenser still need individual confirmation. ^[2]

Know who interprets concerns, what monitoring is included and where a clinical question goes. The platform is not comprehensive or emergency care. A catalogue-wide promise of ongoing support should be assessed against the contact and follow-up attached to the chosen prescription. ^{[2] [3]}

For another focused prescription-care relationship, read our Nurx review.

Keep the outcome with the finished product

Raeliva acknowledges that its weight-care compounds were not the products used in the branded trials it displays, and that its dissolving tablets were not studied in those trials. FDA also distinguishes compounded medicines from approved products and recommends compounded GLP-1 use for medical needs an approved drug cannot meet. ^{[5] [6] [11]}

NAD+ energy biology and sermorelin’s hormone signaling raise different evidence questions. Neither mechanism establishes improved function, fewer clinical events or longer healthy life from the selected prescription. A broad longevity label cannot combine these separate uncertainties into a demonstrated benefit. ^{[12] [13]}

Keep the actual product and outcome specific with the SELECT cardiovascular evidence.

Separate measured outcomes with lean mass and physical function.

Review the patient agreement before a long term

The public refund policy excludes completed consultations and processed, dispensed or shipped prescriptions, while describing limited pre-processing and verified-error exceptions. It asks for cancellation and written confirmation before future charges stop. This is narrower than a result-based guarantee. ^[4]

The care-roles page says CareValidate maintains the patient-facing clinical, subscription and refund terms. Obtain the actual selected agreement before payment. The marketing site’s cancellation wording and general terms do not settle every renewal or unused-balance question in that separate transaction. ^{[2] [3]}

Consider continuity alongside the evidence after GLP-1 treatment stops.

Compare the useful addition to care

I would compare Raeliva with other services after defining the actual intervention and follow-up needed. A clinical-access service, a biomarker package and a behavioral subscription can each address different gaps; a broader menu is not automatically a more useful purchase.

The decision needs a coherent clinical purpose, a complete selected bill and a practical route for follow-up. Testimonials and cumulative patient totals cannot supply evidence of a healthspan benefit. Choose the service for what it helps you and your clinician do, rather than the promise implied by a longevity category. ^{[1] [6]}

For a different testing and medication package, compare our Noom Proactive Health review.

For a narrower longevity add-on and metabolic-care arrangement, read our OrderlyMeds review.

Understanding the cost

Examples: NAD+ and sermorelin each $179 monthly or $1,400 prepaid for twelve months; semaglutide injection $219 monthly or $900 for six months; tirzepatide injection $299 monthly or $1,450 for six. Routes and terms are distinct. Required labs may add cost; confirm the actual supply, final charge and CareValidate patient agreement. ^{[2] [7] [8] [12] [13]}